Death-associated protein kinase 1 variation and Parkinson's disease

J. C. Dachsel, C. Wider, C. Vilariño-Güell, J. O. Aasly, A. Rajput, A. H. Rajput, T. Lynch, D. Craig, A. Krygowska-Wajs, B. Jasinska-Myga, G. Opala, M. Barcikowska, K. Czyzewski, R. M. Wu, M. G. Heckman, R. J. Uitti, Z. K. Wszolek, M. J. Farrer, O. A. Ross

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background and purpose: Mutations of the LRRK2 gene are now recognized as major risk factors for Parkinson's disease. The Lrrk2 protein is a member of the ROCO family, which also includes Lrrk1 and Dapk1. Functional genetic variants of the DAPK1 gene (rs4877365 and rs4878104) have been previously associated with Alzheimer's disease. Methods: Herein, we assessed the role of DAPK1 variants (rs4877365 and rs4878104) in risk of Parkinson's disease with Sequenom iPLEX genotyping, employing one Taiwanese series (391 patients with Parkinson's disease, 344 controls) and five separate Caucasian series' (combined sample size 1962 Parkinson's disease patients, 1900 controls). Results: We observed no evidence of association for rs4877365 and rs4878104 and risk of Parkinson's disease in any of the individual series or in the combined Caucasian series under either an additive or recessive model. Conclusion: These specific DAPK1 intronic variants do not increase the risk of Parkinson's disease. However, further functional studies are required to elucidate the potential therapeutic implications with the dimerization of the Dapk1 and Lrrk2 proteins.

Original languageEnglish (US)
Pages (from-to)1090-1093
Number of pages4
JournalEuropean Journal of Neurology
Issue number8
StatePublished - Aug 2011


  • DAPK1
  • Genetics
  • LRRK2
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Death-associated protein kinase 1 variation and Parkinson's disease'. Together they form a unique fingerprint.

Cite this